Non-transfused group (n = 433) | Transfused group (n = 93) | P value | |
---|---|---|---|
Age (years) | 55.3 ± 12.8 | 57.6 ± 12.7 | 0.121 |
Gender (male/female) | 277 (64.0 %) / 156 (36.0 %) | 66 (70.9 %) / 27 (29.1 %) | 0.199 |
Body mass index (kg/m2) | 24.6 ± 3.4 | 23.6 ± 3.5 | 0.011 |
Hypertension | 176 (40.6 %) | 37 (39.8 %) | 0.878 |
Diabetes mellitus | 68 (15.7 %) | 17 (18.3 %) | 0.540 |
Coronary artery disease* | 19 (4.4 %) | 7 (7.5 %) | 0.196 |
Respiratory disease† | 25 (5.8 %) | 9 (9.7 %) | 0.167 |
History of abdominal operation | 98 (22.6 %) | 17 (18.3 %) | 0.408 |
Preoperative laboratory values | |||
Albumin (g/dL) | 4.1 ± 0.5 | 3.6 ± 0.7 | <0.001 |
Albumin <3.5 g/dL | 36 (8.3 %) | 39 (41.9 %) | <0.001 |
Hemoglobin (g/dL) | 13.5 ± 1.9 | 11.6 ± 2.2 | 0.009 |
Hemoglobin <12.0 g/dL | 72 (16.6 %) | 49 (52.7 %) | <0.001 |
Prothrombin time (INR) | 0.99 ± 0.08 | 1.04 ± 0.10 | <0.001 |
Platelet (×109/L) | 253.0 ± 78.1 | 293.8 ± 129.2 | 0.004 |
Creatinine (mg/dL) | 1.3 ± 2.0 | 1.4 ± 2.3 | 0.965 |
Uric acid (mg/dL) | 5.3 ± 1.5 | 5.3 ± 1.6 | 0.258 |
Crystalloid infused (mL) | 1757.6 ± 760.4 | 3897.3 ± 2758.5 | <0.001 |
Colloid infused (mL) | 158.2 ± 268 | 1145.2 ± 861.9 | <0.001 |
Operative time (min) | 193.4 ± 57.7 | 332.5 ± 171 | <0.001 |
Cancer stage‡ | <0.001 | ||
I | 239 (96.0 %) | 10 (4.0 %) | |
II | 67 (82.7 %) | 14 (17.3 %) | |
III | 85 (74.6 %) | 29 (25.4 %) | |
IV | 38 (52.1 %) | 35 (47.9 %) | |
Urologist | 0.570 | ||
A | 154 (85.6 %) | 26 (14.4 %) | |
B | 115 (80.4 %) | 28 (19.6 %) | |
C | 73 (80.2 %) | 18 (19.8 %) | |
D | 91 (81.3 %) | 21 (18.8 %) |